For years, athletes have chased every possible advantage, from specialized training and strict diets to performance-enhancing drugs. Now, GLP-1 medications, which can curb appetite and support weight loss, are entering the conversation. As more athletes turn to these drugs, a new question is emerging: Could they give athletes an unfair edge?
GLP-1 medications such as semaglutide and tirzepatide mimic the gut hormones that signal fullness. Originally developed to treat Type 2 diabetes by helping the body regulate blood sugar levels, they are now also widely used to manage obesity and weight. Tennis star Serena Williams has openly discussed using tirzepatide after struggling to lose weight following pregnancy. The high-profile athlete reported improvements in her cardiovascular health, cholesterol, and joint health, fueling debate over whether GLP-1s could also affect athletic performance.
For a substance to be classified as doping, it must enhance performance, present a risk to the athlete’s health, and violate the “spirit of sport.” GLP-1 drugs could potentially raise questions on all three fronts. Losing excess weight would be particularly advantageous in sports with strict weight categories such as boxing and wrestling. It may help athletes move faster, improve endurance, or reduce inflammation, indirectly affecting sports results.
On the other hand, no solid evidence exists that GLP-1 agonists have any inherent performance-enhancing effect in healthy athletes. If anything, they could hurt performance by causing muscle loss and digestive problems. Athletes must also watch out for underfueling from not consuming enough calories. Too little energy can undermine recovery, training, and overall performance.
For now, GLP-1 medications are not banned in sports, although the World Anti-Doping Agency is monitoring them for potential misuse. In the meantime, the sports world is calling for more research on the matter and questioning whether it is ethical for athletes to use these drugs without a medical need, especially when their choices could influence younger fans.
Yesel Kang Copy Editor teen/1788757165/1613367750
1. Why are GLP-1 medications debated in sports?
2. How might weight loss benefit certain athletes?
3. What risks could GLP-1 drugs create?
4. Why are GLP-1 drugs not currently banned?
1. Should medically unnecessary GLP-1 use count as doping?
2. Can weight loss unfairly improve athletic performance?
3. Should sports organizations regulate emerging medications earlier?
4. How should athletes influence younger fans responsibly?
For years, athletes have chased every possible advantage, from specialized training and strict diets to performance-enhancing drugs.
GLP-1 drugs could potentially raise questions on all three fronts.
